Argenx Se (ARGX) Short-term Investments (2015 - 2026)

Argenx Se (ARGX) posted quarterly Short-term Investments of $1.6 billion for Q2 2026, down 99.86% year-on-year from $1154.3 billion in Q2 2025, and up 68.6% on a QoQ basis from $949.0 million in Q4 2025.

Argenx Se (ARGX) Short-term Investments (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Short-term Investments for 12 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

  • Quarterly Short-term Investments fell 99.86% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (down 99.86% YoY) and the FY2025 annual result came in at $2.4 billion, up 209.38% from the prior year.
  • Short-term Investments grew to $1.6 billion in Q2 2026 per ARGX's latest filing, from $949.0 million in the prior quarter.
  • Over the last five years, Short-term Investments for ARGX reached as high as $1154.3 billion in Q2 2025 and fell as low as -$1108.4 billion in Q2 2024.
  • A 5-year average of $6.1 billion and a median of $1.2 billion in 2022 frame the typical range for Short-term Investments.
  • Annual changes were most pronounced in 2024 — Short-term Investments tumbled 125146.11% — and 2025, when it soared 204.14%.
  • Year by year, Short-term Investments stood at $1.4 billion in 2022, then decreased by 18.74% to $1.1 billion in 2023, then jumped by 66.13% to $1.9 billion in 2024, then slumped by 49.49% to $949.0 million in 2025, then surged by 68.6% to $1.6 billion in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods registered $1.6 billion, $949.0 million, and $1154.3 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Bn
Dec 31, 2025 949.00 Mn
Jun 30, 2025 1,154.26 Bn
Dec 31, 2024 1.88 Bn
Jun 30, 2024 -1,108.41 Bn
Dec 31, 2023 1.13 Bn
Jun 30, 2023 886.40 Mn
Dec 31, 2022 1.39 Bn
Jun 30, 2022 1.23 Bn
Dec 31, 2021 1.00 Bn
Jun 30, 2021 1.15 Bn
Dec 31, 2020 723.01 Mn
Jun 30, 2020 832.25 Mn
Dec 31, 2019 1.14 Bn
Jun 30, 2019 883.61 Mn
Dec 31, 2018 322.64 Mn
Jun 30, 2018 285.73 Mn
Dec 31, 2017 243.77 Mn
Jun 30, 2017 141.28 Mn
Dec 31, 2016 9.86 Mn